In turn, YAP in HCC cells activates the AKT/Mechanistic target of rapamycin (mTOR)/sterol regulatory element-binding protein 1 (SREBP1) pathway which accelerates HCC cell growth by lipogenesis induction [70]. Here, AKT1 is linked to hepatocellular carcinoma.